Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aging
FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles
March 16th, 2008
Light BioScience(R), LLC, the leader in the science of LED (light emitting diode) Photomodulation, announced that it has become the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for the treatment of periorbital wrinkles. This clearance paves the way for future development of a new anti-aging device to deliver the GentleWaves LED Photomodulation(R) technology directly to the consumer marketplace without a prescription. Currently used by physicians around the world, GentleWaves has been scientifically proven to reduce the appearance of fine lines and wrinkles through the use of a patented...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-16)
|
